Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v6-EN
Language English English
Date Updated 2021-12-09 2021-11-15
Drug Identification Number 00761850 00761850
Brand name DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP
Common or Proper name Dopamine Dopamine
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients DEXTROSE DOPAMINE HYDROCHLORIDE DEXTROSE DOPAMINE HYDROCHLORIDE
Strength(s) 50MG .8MG 50MG .8MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 250mL (18 bags per case) 250mL (18 bags per case)
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2021-09-30 2021-09-30
Actual start date 2021-09-30 2021-09-30
Estimated end date 2021-12-08 2021-11-18
Actual end date 2021-12-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 800mg/250mL bags (DIN 00761834) are available as alternatives if they align with clinical practice. Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 800mg/250mL bags (DIN 00761834) are available as alternatives if they align with clinical practice.
Health Canada comments